RPSC declares final results for Rajasthan State & Subordinate Services Exam. Check merit list, roll numbers, categories, and PDF at rpsc.rajasthan.gov.in. RPSC RAS final Result out: The Rajasthan ...

The RPSC has announced the RAS mains result 2025, with 2,461 candidates declared successful. The mains exam was held on June 17 and 18, 2025, across multiple centres in Rajasthan in two shifts daily.

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Reggae artiste Ras-I will readily admit that 2025 has been one of his best musical years yet. Earlier this year the singer’s 2020 hit single Somewhere Wonderful was selected as the official soundtrack ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

A meeting of the search committee regarding the appointment of a permanent Chairman of the Higher Education Commission (HEC) was held on Wednesday, while Education Secretary Nadeem Mahbub has assumed ...

The search committee tasked with appointing the new Chairman of the Higher Education Commission (HEC) has failed to make the appointment within the stipulated timeframe and has not yet finalised the ...

The Higher Education Commission (HEC) of Pakistan has launched a major digital transformation initiative to improve public universities across the country. This project aims to replace old, ...

ISLAMABAD – The court has reinstated Professor Dr. Zia-ul-Qayyum as the Executive Director of the Higher Education Commission (HEC) after suspending his termination orders issued earlier this year.

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.